Anticoagulation Medicine in Surgical Repair for Total Anomalous Pulmonary Venous Connection

Summary

Total anomalous pulmonary venous connection (TAPVC) is a complex congenital heart disease, requiring surgical repair. Pulmonary venous obstruction (PVO) is the major complication, with limited effective reinterventions and poor outcomes. This trial aims at investigating that postoperative anticoagulant management reduce the incidence of PVO.

Timeline

Start

2020-02-20

Primary completion

2021-10-01

Completion

2022-03-01

Drugs

Indications